UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
LNAI holding history
Lunai Bioworks Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LNAI overviewAll 13F holders of LNAIFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −1,430−100.0% | Sold outConverted for a 1-for-8 split | Holders |
| Q1 2026 | 11,439 | $4.66K | <0.1% | −6,501−36.2% | Reduced | Holders |
| Q4 2025 | 17,940 | $15.8K | <0.1% | −19,430−52.0% | Reduced | Holders |
| Q3 2025 | 37,370 | $4.86K | <0.1% | +24,911+199.9% | AddedConverted for a 1-for-10 split | Holders |
| Q2 2025 | 124,595 | $36.0K | <0.1% | −579,245−82.3% | Reduced | Holders |
| Q1 2025 | 703,840 | $382.2K | <0.1% | −59,861−7.8% | Reduced | Holders |
| Q4 2024 | 763,701 | $638.5K | <0.1% | +717,245+1,543.9% | Added | Holders |
| Q3 2024 | 46,456 | $22.4K | <0.1% | +26,667+134.8% | Added | Holders |
| Q2 2024 | 19,789 | $34.6K | <0.1% | +17,940+970.3% | Added | Holders |
| Q1 2024 | 1,849 | $4.90K | <0.1% | −6,298−77.3% | Reduced | Holders |
| Q4 2023 | 8,147 | $25.8K | <0.1% | +2,125+35.3% | Added | Holders |
| Q3 2023 | 6,022 | $26.9K | <0.1% | +6,022 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −7,369−100.0% | Sold out | Holders |
| Q1 2023 | 7,369 | $6.74K | <0.1% | +1,263+20.7% | Added | Holders |
| Q4 2022 | 6,106 | $6.29K | <0.1% | +6,106 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −2,040−100.0% | Sold out | Holders |
| Q1 2022 | 2,040 | $17.0K | <0.1% | +1,864+1,059.1% | Added | Holders |
| Q4 2021 | 176 | $1.00K | <0.1% | +161+1,073.3% | Added | Holders |
| Q3 2021 | 15 | $0 | 0.0% | −245−94.2% | Reduced | Holders |
| Q2 2021 | 260 | $1.00K | <0.1% | −3,291−92.7% | Reduced | Holders |
| Q1 2021 | 3,551 | $13.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.